Asset
Ruxolitinib Phosphate
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00778700 | phase2 | completed | 2008-10-28 | 2009-06-26 | Incyte Corporation | A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis |
| NCT03257644 | phase1 | completed | 2017-09-21 | 2020-10-07 | Incyte Corporation | A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis |
| NCT02553330 | phase2 | terminated | 2015-11-18 | 2017-10-03 | Incyte Corporation | A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) |
| NCT00820950 | phase2 | completed | 2007-05-31 | 2009-01-31 | Incyte Corporation | A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis |
FDA applications (3)
| Application | Type | Applicant |
|---|---|---|
| NDA 202192 | NDA | INCYTE CORP |
| NDA 215309 | NDA | INCYTE CORP |
| NDA 217180 | NDA | INCYTE CORP |
Marketed products (11)
- JAKAFI
- JAKAFI
- JAKAFI
- JAKAFI
- JAKAFI
- JAKAFI XR
- JAKAFI XR
- JAKAFI XR
- JAKAFI XR
- JAKAFI XR
- OPZELURA